1. A dipeptidyl peptidase inhibitor, evogliptin, directly prevents nephrin loss and podocyte damage via posttranscriptional regulation. (2020) Authors: YH, Cheong; H, Park; IH, Jung; YN, Chae; TH, Kim; BR, Lee; MK, Kim Journal: Diabetes updates Issue: Volume 6:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗